Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

4.4K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

543
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
543
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

152
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
152
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.9K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.9K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

218
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
218
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Decision-Support System for Personalized Antidepressant Treatment in Major Depressive Disorder-Reply.

JAMA·2026
Same author

Acceptability and accuracy of point-of-care monitoring of lithium levels.

The British journal of psychiatry : the journal of mental science·2026
Same author

Psychotherapy, Antidepressants, and Combined Treatment for Depression: A Network Meta-analysis on Social Functioning Outcomes.

Psychotherapy and psychosomatics·2026
Same author

Tool for Converting ADHD Rating Scales Scores Based on Individual Participant Data from 53 Randomized Controlled Trials of ADHD Medications.

Journal of child and adolescent psychopharmacology·2026
Same author

The GALENOS approach to triangulating evidence: a structured approach for integrating information from human and animal studies.

BMC medical research methodology·2026
Same author

Pharmacological interventions for ADHD: a systematic review and dose-effect network meta-analysis.

The lancet. Psychiatry·2026

Related Experiment Video

Updated: Nov 19, 2025

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

1.9K

A Bayesian dose-response meta-analysis model: A simulations study and application.

Tasnim Hamza1, Andrea Cipriani2, Toshi A Furukawa3,4

  • 1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Statistical Methods in Medical Research
|January 28, 2021
PubMed
Summary
This summary is machine-generated.

We introduce a flexible Bayesian hierarchical dose-response model for meta-analysis. This new model shows lower bias, especially with small sample sizes, and offers advantages over frequentist methods for analyzing antidepressant drug efficacy.

Keywords:
Clustersantidepressantshierarchical modelone-stage modelrandom effects

More Related Videos

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.1K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.2K

Related Experiment Videos

Last Updated: Nov 19, 2025

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

1.9K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.1K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.2K

Area of Science:

  • Biostatistics
  • Pharmacometrics
  • Epidemiology

Background:

  • Meta-analysis synthesizes aggregated data to establish dose-response relationships.
  • Frequentist one-stage and two-stage models are commonly used for this purpose.
  • Existing methods may have limitations in flexibility and bias, particularly with small sample sizes.

Purpose of the Study:

  • To propose a novel hierarchical dose-response model within a Bayesian framework.
  • To assess the model's performance through simulation studies and compare it with frequentist approaches.
  • To apply the model to real-world data on antidepressant drug efficacy.

Main Methods:

  • Development of a Bayesian hierarchical dose-response model using restricted cubic splines for flexibility.
  • Implementation in R using JAGS, accommodating normal or binomial likelihoods and clustered exposures.
  • Comparison via simulation with frequentist one-stage meta-analysis models.
  • Re-analysis of data from 60 randomized controlled trials on SSRI antidepressant efficacy.

Main Results:

  • The Bayesian model with binomial likelihood demonstrated lower bias than normal likelihood and frequentist models in small sample scenarios.
  • Model performance was sensitive to knot placement for log-log or half-sigmoid dose-response shapes.
  • In most scenarios, all models yielded comparable results.
  • Analysis of SSRI data indicated efficacy increases up to 30-40 mg fluoxetine-equivalent dose, followed by a slight decline.

Conclusions:

  • The proposed Bayesian hierarchical model offers a flexible and robust alternative to frequentist dose-response meta-analysis.
  • It shows improved performance, particularly with small sample sizes and complex dose-response curves.
  • The model provides valuable insights into antidepressant drug efficacy, accommodating variations in study design and drug types.